The Proteomic Profile of Keratinocytes and Lymphocytes in Psoriatic Patients

Proteomics Clin Appl. 2019 Jul;13(4):e1800119. doi: 10.1002/prca.201800119. Epub 2019 Jan 25.

Abstract

Purpose: Psoriatic skin lesions are associated with chronic inflammation related to immune cell activity. Therefore, the aim of this study is to compare changes in the proteome of psoriatic keratinocytes and lymphocytes.

Experimental design: A proteomics approach is used to analyze the expression of proteins in keratinocytes and lymphocytes from psoriatic patients and healthy controls.

Results: As a result 2119 proteins for keratinocytes and 1235 proteins for lymphocytes are identified. Psoriatic keratinocytes has 68 downregulated and 7 upregulated proteins and psoriatic lymphocytes has 106 downregulated and 67 upregulated proteins compared to healthy individuals. The list of downregulated proteins includes proteins involved in antioxidant homeostasis and, transcription regulation; upregulated proteins are involved in glycolytic processes and translation. These changes are accompanied by an increased level of 4-Hydroxynonenal-protein adducts; control cells are characterized by 4-Hydroxynonenal-Lysine adducts formed with structural and binding proteins, while in psoriatic cells 4-Hydroxynonenal-Lysine, 4-Hydroxynonenal-Histidine, and 4-Hydroxynonenal-Cysteine adducts with various molecular function proteins occur.

Conclusions and clinical relevance: This study highlights the changes in psoriatic keratinocytes and lymphocytes that can be directly involved in the development of psoriasis. In both cell types the most significant changes are associated with upregulation of phosphoglycerate mutase 1 and downregulation of thioredoxin reductase.

Keywords: 4-HNE-protein adducts; keratinocytes; lymphocytes; proteome; psoriasis.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Gene Expression Regulation, Enzymologic*
  • Humans
  • Keratinocytes / enzymology*
  • Keratinocytes / pathology
  • Lymphocytes / enzymology*
  • Lymphocytes / pathology
  • Male
  • Middle Aged
  • Phosphoglycerate Mutase / biosynthesis*
  • Proteome / biosynthesis*
  • Psoriasis / enzymology*
  • Psoriasis / pathology
  • Thioredoxin-Disulfide Reductase / biosynthesis*

Substances

  • Proteome
  • Thioredoxin-Disulfide Reductase
  • Phosphoglycerate Mutase
  • phosphoglycerate mutase 1, human